Ann: Positive Guidance from FDA on Phase 3 Prostate Cancer Trial, page-50

The PR’s are for DISCO and CL04.

The way the PR’s work is that they are issued to incentivise CU6 progressing DISCO thru to marketing approval. Once marketing approval is received, CU6 can use the PR for another program. They could use it for CL04, for example. If CL04 got marketing approval, they could use the CL04 PR for another program.

My thoughts are, CU6 accelerates PROPELLER, gets income to focus on/accelerate DISCO. Now, potentially, CU6 can sell the DISCO PR to fund CL04.

If CL04 gets marketing approval, the PR can be used in-house, or, sell it to fund other programs. At this stage, CU6 would have free cashflow and may not want to sell the CL04 PR.

Happy for any thoughts.

I suppose I’m just trying to have current funds focussed on PROPELLER and hopefully it’s approved some time in 2024.